Best Intraday Stocks to buy – Vaishali Parekh

The Indian equity market traded in a tight range, with the Nifty 50 ending marginally higher as consolidation within the 25,350–25,700 corridor continued to dictate near-term direction. This zone has now evolved into a key support–resistance band, indicating a stabilising market that still lacks decisive momentum.

Sectoral activity remained largely subdued, though pharma stocks outperformed. The Nifty Pharma index advanced 0.9% during the session and has gained nearly 6.3% over the past month. The strength was supported by improved sentiment following recent reductions in US tariff rates, offering relief to export-oriented drugmakers and triggering selective buying interest.

Nifty Outlook

According to Vaishali Parekh, Vice President – Technical Research at Prabhudas Lilladher, the broader sentiment remains cautiously positive, with the Nifty oscillating between its 50-DEMA and 200-DEMA levels.

Parekh noted that the index once again witnessed a narrow range-bound session, closing near the 25,500 mark. A decisive move above 25,650 (50-EMA zone) is required to establish conviction for a sustained upside in the coming sessions. On the downside, the index must hold above 25,350 (200-DMA zone) to maintain the positive bias.

Bank Nifty Outlook

Bank Nifty continues to trade within a prolonged consolidation band between 60,800 and 61,500, awaiting a clear breakout for directional clarity.

Parekh highlighted that a meaningful revival above the 61,800 hurdle could trigger a fresh upward move, while the 50-DEMA near 59,970 remains a critical support level that must be sustained to preserve the prevailing bias.

For the immediate session, Nifty support stands at 25,350 and resistance at 25,650, while Bank Nifty is expected to trade within a 60,500–61,800 range.